Advanced Bio,
People-centered Value Creation

Vaccines are pharmaceuticals to protect human bodies from any potential infections by assisting the human immune system. Vaccines are also heroes which have innovated the healthcare trend from a treatment focus to prevention focus. The GBC 2019 will share the most up-to-date technological trends of vaccines which are the modern medical development indexes and also listen to what the regulatory authorities including WHO said. 

#1. Next generation vaccine development leveraging RNA technology 

mRNA(messenger RNA) based vaccine development is increasingly growing. mRNA is a medium for transcription of the gene in the nucleus to be translated into protein. Targeting mRNA is more effective than other drugs targeting proteins and less risky that modifying the gene in the nucleus (genome integration risk). The mRNA based treatments cover a wide span of diseases from Cancer-immunotherapies to respiratory cell virus vaccines including rabies or Ebola virus. The CureVac AG presentation by Lidia Oostvogels will offer an introduction on responsiveness profile result and LNP( lipid nanoparticle) agents!

#2.Quality assessment considerations when reviewing new vaccines for approval    

PEI(Paul-Ehrlich-Institut) is a senior federal authority in the field of pharmaceutical products providing services in public health under the German Public Health Service. It engages in biopharmaceutical products review for approval, national lot release, pharmacovigilance and runs own experimental research in the field of life science.  It is also involved in international cooperation with international organizations including WHO. 

We shall take a look at the ethical handling and safe management control of the human tissues which have been donated for transplant and will share the best practice regulatory trend and global issues in human tissues.